Fort Lauderdale, FL, June 6, 2018 - OmniComm Systems, Inc. (OTCQX: OMCM), a leading global provider of clinical data management technology, today announced a partnership with Kayentis, a global provider of electronic Clinical Outcome Assessment (eCOA) solutions for patient data collection in clinical trials. Under the terms of the partnership, the two companies will work together to provide life science clients with OmniComm’s TrialMaster® electronic data capture (EDC) suite integrated with Clin’form®, eCOA solution Suite from Kayentis - thereby offering an enhanced integration of the two platforms.
Prior to the partnership, a number of clients had independently selected both OmniComm and Kayentis for best-in-class data capture solutions. Therefore, the strategic relationship represents a logical fit and brings an exciting opportunity to streamline EDC and eCOA data capture, according to executives from both companies.
“After successfully implementing projects alongside OmniComm, we are thrilled to grow our partnership and bring it to this new step. Both companies share strong values and strive to provide customers, clinical sites and patients with the most efficient, easy-to-use and comprehensive solutions,” said Guillaume Juge, CEO at Kayentis.
Smart phones, tablets and other devices serve an expanding role in clinical trials as doctors, nurses and other researchers increasingly use mobile devices to collect trial data. Likewise, patients using mobile devices and wearable technology have heightened the need for electronic patient-reported outcome (ePRO) solutions.
Through joint marketing and business development initiatives, the two companies will work together to deliver OmniComm’s EDC technology and services integrated with eCOA solutions from Kayentis.
“OmniComm is delighted to be forging a formal relationship with Kayentis that will benefit our clients who need eCOA technology,” said Stephen Johnson, president & CEO of OmniComm Systems. “More and more, we see the voice of the patient/subject becoming critical to the success of studies, and we feel that Kayentis’ technology and support will bring enormous value.”
About Kayentis
Kayentis is a global provider of electronic Clinical Outcome Assessment (eCOA) solutions for patient data collection in clinical trials. Created in 2003, Kayentis has specialized in eCOA solutions since 2009, developing a full range of services and extending its solutions portfolio to support pharmaceutical companies, biotechnology companies and CROs. Today, with experience of more than 150 clinical trials in 75+ countries (6,500 sites and 50,000 patients) and in a broad range of therapeutic areas, Kayentis adds value to data quality and clinical trial efficiency with innovative and intuitive solutions. Please visit kayentis.com for more information.
About OmniComm Systems, Inc.
OmniComm Systems, Inc. is a leading strategic software solutions provider to the life sciences industry. OmniComm is dedicated to helping the world’s pharmaceutical, biotechnology, contract research organizations, diagnostic and device firms, and academic medical centers maximize the value of their clinical research investments. Through the use of innovative and progressive technologies, research organizations drive efficiency in clinical development, better manage risks, ensure regulatory compliance and manage their clinical operations performance. OmniComm provides comprehensive solutions for clinical research with an extensive global experience from more than 6,000 clinical trials. Please visit www.omnicomm.com for more information.
Trademarks
OmniComm, TrialMaster and TrialOne are registered trademarks of OmniComm Systems, Inc. Clin’form is a registered trademark of Kayentis.
Contact Info
Kuno van der Post
OmniComm Systems, Inc.
+1.954.473.1254
KvanderPost@omnicomm.com
Guillaume Juge Kayentis
+33476005420
Gjuge@kayentis.com
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Empower Sponsor Success with Insights from Sites
October 3rd 2024Are you tired of clinical trial technology that slows down processes? Are your sites looking for more intuitive solutions? At YPrime, we’ve taken a deep dive into site experiences and perspectives, sharing ways to bridge the gap between sponsors, sites, and patients, to foster a more efficient clinical trial process.